Diffuse Large B-Cell Lymphoma (DLBCL) is the most common and the most aggressive subtype constituting nearly 70% of B-Cell Lymphomas in Asia.
Novotech Awarded Cell & Gene Therapy CRO Excellence 2023
Singapore – 19 September 2023 - Novotech, the leading Asia Pacific centred biote
Read more